Stay up to date on our latest NeuroBlu news and developments.
Real-world data reveals differences between diagnoses and phenotypes, and how polypharmacy affects functioning in patients.
May 24, 2022
Holmusk offers new insights on the association between comorbid substance use disorders and illness severity in people with schizophrenia.
May 18, 2022
Holmusk offers new real-world evidence into patients with difficult-to-treat depression.
May 16, 2022
Holmusk publishes paper in BMJ Open, centering on dataset available in NeuroBlu, and platform capabilities.
April 26, 2022
Holmusk provides new insights into schizophrenia that could support more individualized care pathways.
April 8, 2022
Expanded dataset to enhance real-world impact. Boost efficiency with Help & Resources.
April 1, 2022
Filter search results and view data by categories. Download cohort visualizations to document your research.
February 4, 2022
Holmusk presents results from the largest analysis to date evaluating treatment of ADHD for young children.
January 15, 2022
Study uses Real-World Data to describe important patterns in the treatment of opioid use disorder.
January 5, 2022
Build dynamic risk models. New functions in Code Studio to conduct research studies faster.
November 1, 2021
Holmusk publishes abstract in American Academy of Child and Adolescent Psychiatry (AACAP) 68th Annual Meeting.
October 18, 2021
Enhanced experience with smoother onboarding journey, new CGI-S filter and new project organization tools.
October 12, 2021
Holmusk presents at American Society for Clinical Pathology (ASCP) 2021 Annual Meeting.
August 22, 2021
Holmusk invites start-ups and academics to submit proposals for projects using NeuroBlu.
August 21, 2021
Use Python to perform customized research studies on NeuroBlu.
July 1, 2021
Conduct advanced analytics with ease, with enhanced visualizations and documentation of research notes.
March 31, 2021